Full-Time

Product Manager

Posted on 6/26/2025

Strata Decision Technology

Strata Decision Technology

201-500 employees

Healthcare financial planning and analytics platform

Compensation Overview

$93k - $120k/yr

+ Discretionary variable pay programs

Chicago, IL, USA

Hybrid

Hybrid role with flexible work from home; preferred locations Chicago, IL or St. Louis, MO.

Category
Product (1)
Required Skills
Agile
Market Research
Product Management
SCRUM
Requirements
  • 3+ years of product management or equivalent experience
  • 3+ years of healthcare finance experience
  • Fluent in Agile and Scrum software development methodologies
  • Advanced written and verbal communication with the ability to interact effectively with a wide variety of internal and external stakeholders
  • Excellent presentation and listening skills, with ability to think quickly and deliver consultative response
  • Strong project management skills with the ability to manage multiple projects at one time
  • Ability to make real-time autonomous decisions when conditions change, based on understanding of the user context, business objectives, and customer needs
Responsibilities
  • Specify market requirements for current and future products by conducting market research
  • Work with engineering and design teams to refine requirements and build defined features
  • Maintain the backlog and attend agile ceremonies for a scrum team
  • Collaborate with the product management team to align the roadmap with the company and product strategy
  • Communicate product vision to key stakeholders within the organization
  • Develop and implement a company-wide go-to-market plan, working with all departments to execute.
Strata Decision Technology

Strata Decision Technology

View

Strata Decision Technology offers SaaS financial planning, analytics, and performance management tools aimed at healthcare. Its flagship StrataJazz helps hospitals and health systems with budgeting, forecasting, cost accounting, and financial insights through a subscription model with continuous updates. The company differentiates itself with deep healthcare domain knowledge, strong customer satisfaction, and a broad client base plus best-practice insights from its user community. Its goal is to help organizations make better financial decisions, improve efficiency, and lower costs to support sustainable patient care.

Company Size

201-500

Company Stage

Acquired

Total Funding

N/A

Headquarters

Chicago, Illinois

Founded

1996

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven Predictive Analytics launches in 2026 to forecast risks amid negative margins.
  • Over 100 health systems use Epic-integrated StrataJazz, rated #1 in KLAS for decision support.
  • SaaS model with consulting ensures recurring revenue from diverse healthcare and education clients.

What critics are saying

  • Workday Healthcare Performance Cloud erodes StrataJazz market share in 12-24 months.
  • Epic embeds free financial modules, making StrataJazz redundant for 40% of clients by 2029.
  • Oracle Health AI suite captures hospitals via EHR integration within 6-12 months.

What makes Strata Decision Technology unique

  • StrataJazz integrates directly with Epic via collaborative development for seamless cost data flow.
  • StrataSignal AI engine powers Predictive Analytics for monthly healthcare financial forecasts.
  • Comparative Analytics benchmarks 2,300 organizations' financial and operational data monthly.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Flexible Work Hours

Performance Bonus

Company News

The Associated Press
Mar 31st, 2026
Strata Decision Technology launches AI-driven predictive analytics for healthcare finance

Strata Decision Technology has launched Predictive Analytics, an AI-driven solution designed to help healthcare systems forecast financial performance and identify risks earlier. The platform addresses challenges facing health systems operating with shifting volumes, reimbursement uncertainty and tight margins, where traditional manual forecasting often leaves finance teams with outdated views. The solution offers monthly predictions using volume and financial data, refreshed automatically as new information becomes available, and annual predictions that provide a continuously evolving view of year-end performance. Powered by StrataSignal, Strata's AI intelligence engine, the platform integrates with existing StrataJazz products to deliver early signals about performance changes and their financial impact. Over 2,300 organisations currently use Strata's enterprise performance management software and data-driven intelligence solutions.

Yahoo Finance
Mar 12th, 2026
US health system margins turn negative as drug costs surge 17% and revenue softens

Health system operating margins turned negative to start 2026, falling to negative 0.6% in January from 1.3% in December 2025, according to Strata Decision Technology's latest performance report. The decline resulted from revenue decreasing faster than expenses, with gross operating revenue down 2.3% month-over-month whilst total expenses fell just 0.6%. Non-labour expense growth has outpaced labour expense increases since Q4 2024, with the gap widening throughout 2025. By Q4 2025, non-labour expenses rose 13.4% compared to the Q4 2023 baseline, whilst labour expenses increased 10.1%. Drug expenses drove much of this growth, rising 17.4% per adjusted patient day compared to 7.2% for medical supplies. Gross outpatient revenue grew 16.8% versus 9% for inpatient revenue, reflecting ongoing shifts in care delivery.

HIT Consultant
Apr 25th, 2025
Health System Margins Fall Below 1% In March Despite Rising Volumes, Revenues

What You Should Know: – U.S. hospitals nationwide experienced increases across most metrics—including revenues, patient volumes, and expenses—to close the first quarter of 2025. However, operating margins for health systems dipped below the 1% threshold in March for the first time in 15 months, according to new data released by Strata Decision Technology. – While individual hospitals continued to show margin improvement, escalating non-labor costs put renewed pressure on overall health system financial performance.Health System Margins Dip Below 1% Despite Hospital GainsThe median year-to-date (YTD) operating margin for U.S. health systems narrowed slightly to 0.9% in March, Strata’s data revealed. This represents a dip from the 1% margin maintained in both January and February, and a more significant decline from the 2.1% reported in December 2024. The last instance of the median YTD system margin falling below 1% was in December 2023, when it also stood at 0.9%.In contrast, individual hospitals maintained positive momentum

HIT Consultant
Mar 27th, 2025
Hospital Margins Plateau In February Amidst Rising Expenses And Mixed Patient Demand

Hospital Margins Plateau in February Amidst Rising Expenses and Mixed Patient Demand. by Jasmine Pennic 03/27/2025 Leave a Comment. What You Should Know: – New data from Strata Decision Technology indicates that operating margin performance for health systems across the nation plateaued in February, as rising expenses continue to limit growth. – The new data finds individual hospitals saw increases in some key performance metrics compared to the previous year, overall trends in hospital margins were mixed, and patient demand decreased across most measures.Operating Margins Remain StagnantThe median year-to-date (YTD) health system operating margin was 1.0% for February 2025, unchanged from January’s 1.0% but down from 2.1% in December 2024.Mixed Trends in Hospital MarginsThe median change in hospital operating margin increased 1.4 percentage points from February 2024 to February 2025.However, it decreased 1.4 percentage points from January to February 2025.The median operating earnings before interest, taxes, depreciation, and amortization (EBITDA) margin rose 1.1 percentage points year over year (YOY).However, it decreased 1.2 percentage points month over month.Rising Expenses Continue to Pressure HospitalsHospitals continue to struggle with increasing expenses.Purchased services had the largest expense increase for the month, at 8.7% YOY.Supply expense rose 6.7% YOY.Drugs expense increased 5.4% YOY.Total non-labor expense increased by 5.7% from February 2024 to February 2025.Total labor expense rose 2.2% YOY.Total expense was up 4.2% YOY.Some Relief Month Over MonthHospitals did experience some relief month over month:Total expense decreased 4.9%.Total labor expense dropped 7.1%.Total non-labor expense decreased 3.1% from January to February 2025.Decreased Patient DemandPatient demand decreased across most metrics and measures in February.Emergency visits had the biggest YOY decrease, with patient volumes down 6.1%.Observation visits were down 4.6% YOY.Outpatient visits decreased 2.7% YOY.Inpatient admissions were the only metric to see an increase, at 1.5% YOY.Month over month, emergency visits dropped 14.8%.Observation visits were down 11.1%.Inpatient admissions decreased 9.3%.Outpatient visits were down 6.9%.Increased Patient Volumes in Some Service LinesPatient volumes increased across some service lines.Infectious disease had the biggest increase, at 15.2% YOY.Nephrology increased 7.5% YOY.Revenue TrendsGross inpatient hospital revenues rose faster than outpatient revenues for the month.Hospitals saw a 22nd month of YOY increases across gross operating, inpatient, and outpatient revenues.Inpatient revenue rose 7.4% from February 2024 to February 2025.Outpatient revenue was up 4.4%.Gross operating revenue increased 5.1%.“Expense increases continue to exert pressure on our nation’s hospitals and health systems in the early months of 2025,” said Steve Wasson, chief data and intelligence officer at Strata Decision Technology. “While expenses are increasing across all categories, non-labor expense increases have outpaced labor expense growth for the past three months. Reining in these increases will be a primary focus for healthcare leaders as we head into the second quarter of the year.”

HIT Consultant
Nov 15th, 2024
Bariatric Surgeries Decline As Glp-1S Use Rises, Impacting Hospital Margins

What You Should Know:– A new report from Strata Decision Technology reveals a significant decline in the number of bariatric surgeries performed in U.S. hospitals in recent years.– The trend coincides with the rising popularity of weight-loss medications like semaglutide (GLP-1s), which have gained widespread adoption since their approval for chronic weight management.Declining Surgical VolumesStrata’s analysis of data from 809 hospitals nationwide shows a clear downward trend in bariatric surgeries. In August 2024, the number of these procedures decreased by over 32% compared to August 2022. This decline corresponds with a substantial increase in semaglutide prescriptions, which jumped over 400% between January 2021 and December 2023, according to a JAMA study.Impact on Hospital MarginsThe decrease in bariatric surgeries has also affected hospital margins. The average total cost margin for these procedures has declined significantly, going from a positive $1,651.63 per procedure in January 2021 to a negative -$504.83 by June 2024. This suggests that hospitals are facing financial challenges as the volume of these profitable procedures decreases.Shifting Landscape of Weight ManagementThe rise of semaglutide and other weight-loss medications is changing the landscape of weight management

INACTIVE